Entera Bio Ltd (ENTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,505 | -11,439 | -8,423 | -5,223 | -2,567 |
| Depreciation Amortization | 7 | 30 | 23 | 15 | 8 |
| Accounts receivable | N/A | 126 | 126 | 126 | N/A |
| Accounts payable and accrued liabilities | -174 | 316 | 84 | 251 | 2 |
| Other Working Capital | -270 | 1,257 | 831 | 1,042 | 555 |
| Other Operating Activity | 852 | 2,340 | 1,822 | 754 | 598 |
| Operating Cash Flow | $-3,090 | $-7,370 | $-5,537 | $-3,035 | $-1,404 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -107 | -80 | -37 | -8 |
| Investing Cash Flow | $N/A | $-107 | $-80 | $-37 | $-8 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 130 | 13,972 | 13,798 | 13,547 | 13,523 |
| Other Financing Activity | 0 | -262 | -262 | -261 | -186 |
| Financing Cash Flow | $130 | $13,710 | $13,536 | $13,286 | $13,337 |
| Exchange Rate Effect | 4 | 36 | 29 | N/A | N/A |
| Beginning Cash Position | 14,973 | 8,740 | 8,740 | 8,740 | 8,740 |
| End Cash Position | 12,017 | 14,973 | 16,688 | 18,954 | 20,665 |
| Net Cash Flow | $-2,960 | $6,233 | $7,948 | $10,214 | $11,925 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,090 | -7,370 | -5,537 | -3,035 | -1,404 |
| Capital Expenditure | N/A | -107 | -80 | -37 | -8 |
| Free Cash Flow | -3,090 | -7,477 | -5,617 | -3,072 | -1,412 |